Product Program year 2025 Source: CMS Open Payments

ID NOW Instrument

Device Rapid Diagnostics

PDI 00811877010616

Open in the dashboard

General payments

$358,264

1,125 payments

Research payments

$257,058

8 payments

Through program year 2025, $358,264 in general payments and $257,058 in research payments were reported against ID NOW Instrument (Rapid Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $35,214 591
2024 General $66,530 156
2023 General $156,875 264
2022 General $96,642 97
2021 General $3,003 17
2021 Research $257,058 8

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $358,264 1,125 payments
Top recipients General payments · program year 2025
  1. Thomas Walsh Infectious Disease · New York, NY $7,370 21% · 4 payments
  2. Margaret Hammerschlag Pediatric Infectious Diseases · Brooklyn, NY $4,124 12% · 3 payments
  3. Antonio Anzueto Pulmonary Disease · San Antonio, TX $3,833 11% · 1 payment
  4. Prov Regl Med Center Everett Teaching hospital · WA $2,500 7% · 1 payment
  5. Yuan Po Tu Internal Medicine · Everett, WA $698 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $7,370 23% · 1 practitioner
  2. Pediatrics $5,797 18% · 185 practitioners
  3. Pediatric Infectious Diseases Pediatrics $4,124 13% · 1 practitioner
  4. Pulmonary Disease Internal Medicine $3,879 12% · 3 practitioners
  5. Family Medicine $2,359 7% · 83 practitioners

The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $11,690 33% · 10 recipients
  2. Texas $7,500 21% · 124 recipients
  3. California $5,483 16% · 156 recipients
  4. Washington $3,259 9% · 5 recipients
  5. Arizona $1,187 3% · 42 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,125 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record